Trial intelligence / Profile preview

Adjunctive brivaracetam for focal seizures in Japan

jRCT2080223559Phase 3Completed

Sponsor
UCB
Start
Jun 2017
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in Focal Onset Epilepsy comparing Briviact adjunctive therapy with Placebo adjunctive therapy (2 arms). Started Jun 2017; status: completed.

02

Drugs

brivaracetam
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on jRCT2080223559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call